The First Enantioselective Organocatalytic Mukaiyama−Michael Reaction: A Direct Method for the Synthesis of Enantioenriched γ-Butenolide Architecture
Abstract
The first enantioselective organocatalytic Mukaiyama−Michael reaction using α,β-unsaturated aldehydes has been accomplished. The use of iminium catalysis has provided a new strategy for the enantioselective addition of 2-silyloxy furans to unsaturated aldehydes to generate a variety of butenolide systems, an important chiral synthon found among many natural isolates. The (2S,5S)-5-benzyl-2-tert-butyl-imidazolidinone amine catalyst has been found to mediate the conjugate addition of a wide variety of substituted and unsubstituted silyloxy furans to unsaturated aldehydes. A diverse range of aldehyde substrates can be accommodated in this new organocatalytic transformation. Application of this new asymmetric technology to the enantioselective total synthesis of spiculisporic acid and the corresponding 5-epi-spiculisporic acid analogue is also discussed.
Additional Information
© 2003 American Chemical Society. Received 25 October 2002. Published online 10 January 2003. Published in print 1 February 2003. Financial support was provided by the NIHGMS (R01 GM66142-01) and kind gifts from AstraZeneca, Boehringer-Ingelheim, Bristol-Myers Squibb, Dupont, GlaxoSmithKline, Johnson and Johnson, Lilly, Materia, Merck Research Laboratories, Pfizer, Pharmacia, and Roche Biosciences. We also thank Great Lakes for their generous donation of (S)-phenylalanine. D.W.C.M is grateful for support from the Sloan Foundation and Research Corporation under the Cottrell Scholarship and Research Innovation programs.Attached Files
Supplemental Material - ja029095q-2_s1.pdf
Files
Name | Size | Download all |
---|---|---|
md5:a3a6abd0a6b207333915ef727e9113a5
|
294.9 kB | Preview Download |
Additional details
- Eprint ID
- 76582
- DOI
- 10.1021/ja029095q
- Resolver ID
- CaltechAUTHORS:20170417-065654426
- NIH
- R01 GM66142-01
- AstraZeneca
- Boehringer-Ingelheim
- Bristol-Myers Squibb
- DuPont
- GlaxoSmithKline
- Johnson and Johnson
- Lilly
- Materia
- Merck Research Laboratories
- Pfizer
- Pharmacia
- Roche Biosciences
- Alfred P. Sloan Foundation
- Cottrell Scholar of Research Corporation
- Created
-
2017-04-17Created from EPrint's datestamp field
- Updated
-
2021-11-15Created from EPrint's last_modified field